Evidence Synthesis
BIOCON's 61.19% gross margin accelerated to, up from 6.91%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 14 Sept 2026, 00:22
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
BIOCON's 61.19% gross margin accelerated to, up from 6.91%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 61.19 % | 6.91 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 6.91 % | 2.86 | ▲ |
| REVENUE_GROWTH_YOY | 10 % | 234.6 | ▼ |
| EPS_ACTUAL | 0.721 INR | 2.738 | ▼ |
| EPS_SURPRISE_PERCENT | -0.254 % | 1.241 | ▼ |
| PRICE_CHANGE_PERCENT | -0.255 % | — | - |
| DAILY_VOLUME | 36,65,623 shares | 45,33,578 | ▼ |
| CLOSE_PRICE | 390.65 INR | 391.65 | ▼ |
| NEWS_SENTIMENT_SCORE | 0.17 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 1 count | 8 | ▼ |
| TARGET_PRICE_PREMIUM | 14.4 % | — | - |